With the ongoing war between Israel and Hamas, The World Health Organization reported a public health update. Officials are concerned about what is happening inside the Gaza Strip particularly around a variety of diseases and health conditions including hepatitis A, skin infections, and even polio.
Following FDA approval, GigaGen's therapy enters Phase 1 clinical trials as the first recombinant human polyclonal therapy for hepatitis B.
Baby formula manufacturer, Perrigo, issued a voluntary recall due to high levels of vitamin D that were above the maximum level permitted.
Part 1, Deborah Birx, MD explains photohydrolysis technology provides continuous, automated disinfection of air and surfaces effective in controlling MRSA and improving infection control practices in healthcare settings.
Kate Broderick, PhD, molecular geneticist, discusses the mRNA capping technology and how it helps create stability to mRNA molecules within vaccines and guides them to cells.
Enhanced diagnostic and surveillance measures for hypervirulent pathogens, new CDC safety data on RSV vaccines showing rare risks, updated IDSA guidance for managing antimicrobial-resistant infections, and more this week from Contagion.
4-way trial assesses non-prescription interventions, including 2 nasal sprays, for reducing seasonal respiratory illness and related antibiotic use.
A large Veterans Health Administration (VA) outpatient study showed a large increase in MRSA resistance in one particular area of the United States and varying antimicrobial resistance patterns overall.
The expanded recall, which now includes approximately 7 million pounds of products, is due to an ongoing investigation linked to 43 reported illnesses, including 3 deaths.
A new phase 1 clinical trial will determine if vaccine candidate, MPV/S-2P, is safe for humans, and may potentially offer protection not seen before in the first-generation of COVID-19 vaccines.
By implementing targeted monitoring and a phased compliance approach, the USDA aims to enhance food safety and public health while maintaining cost-effectiveness and ensuring safer poultry products.
The federal agency says the ongoing outbreak of the clade 1 variant in the Democratic Republic of Congo has been reported in neighboring countries.
The study examines how pathogenicity-related gene clusters integrate into Salmonella's genome to affect disease ability.
Investigators found that 10 days of antibiotics is common for acute otitis media despite that 5 to 7 days is advised by US and international guidelines.
This updated guidance incorporates new treatment strategies and recommendations based on the latest data on antimicrobial resistance.
In this week’s edition of MMWR, the Centers for Disease Control and Prevention reported on the vaccines’ safety profile for each of the FDA approved immunizations and rationale for the recommended age groups.
A single-dose dengue vaccine that is effective across various age groups and independent of prior dengue exposure is essential.
There is a high potential for ActivePure Medical’s technology to enhance patient safety and reduce healthcare costs by minimizing harmful pathogens in complex healthcare environments.
Results demonstrate high safety and reduced need for oxygen supplementation in patients with COVID-19 viral pneumonia.
Analyzing data from over 4.6 million sinusitis cases, the study emphasizes the need for focused efforts to improve adherence to treatment guidelines and ensure antibiotics are used correctly.
Findings affirm the safety and efficacy of using HBsAg-positive donor kidneys in HBsAg-negative recipients, with no adverse effects on posttransplant outcomes.
The World Health Organization (WHO) warns of a moderate global risk to the presence of the pathogen, hypervirulent Klebsiella pneumoniae (hvKp) sequence type (ST) 23, as it has been reported in at least 1 country in all 6 WHO Regions.
Given that over 50% of women experience at least one urinary tract infection annually and antimicrobial resistance is on the rise, it's essential to evaluate the evidence for potential non-drug interventions.
Recent analysis suggests that stricter COVID-19 measures could have saved thousands, Danjuma Adda calls for more funding and awareness to tackle viral hepatitis, our second episode of From Pathogen to Infectious Disease podcast, and more this week.
The prevalence of methicillin-resistant Staphylococcus aureus has surged from 2.58% to 14.79%, highlighting a need for updated treatment strategies.
A large English study shows the incidence rates of arterial thromboses and venous thrombotic events decreased after immunization.
In the second episode with Michael Laposata, MD, PhD, he discusses how lab professionals can communicate with infectious disease clinicians, how AI can be used in diagnostics, and potential point-of-care diagnostic opportunities for the lab.
Providing nirsevimab (Beyfortus) to all newborns and high-risk infants during the 2024-2025 RSV season represents an advancement in protecting infant health.
Increased funding can lead to the development of resources like rapid diagnostic test kits and improve the overall availability of treatment for those in need.
Here is a review of the most up-to-date information around the infection.
